Erratum: TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer (Nature Communications (2014) 5 (4527) DOI: 10.1038/ncomms5527);TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer

Nature Communications

Volumn 5, Issue , 2014, Pages

  Banerjee, Rajat ^a   Russo, Nickole ^a   Liu, Min ^a   Basrur, Venkatesha ^b   Bellile, Emily ^c   Palanisamy, Nallasivam ^b,d   Scanlon, Christina S ^a   Van Tubergen, Elizabeth ^a   Inglehart, Ronald C ^a   Metwally, Tarek ^a   Mani, Ram Shankar ^b   Yocum, Anastasia ^b   Nyati, Mukesh K ^c   Castilho, Rogerio M ^a   Varambally, Sooryanarayana ^b,d   Chinnaiyan, Arul M ^b,d   D'Silva, Nisha J ^a,b,d  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DNA; DNA DEPENDENT PROTEIN KINASE; DOXYCYCLINE; SMALL INTERFERING RNA; ANTINEOPLASTIC AGENT; CARRIER PROTEIN; NUCLEAR PROTEIN; PRKDC PROTEIN, HUMAN; TRIP13 PROTEIN, HUMAN;

CANCER; CELL ORGANELLE; DISEASE TREATMENT; ENZYME ACTIVITY; GENE EXPRESSION; MORTALITY; TUMOR;

3T3 CELL LINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CARCINOGENESIS; CONTROLLED STUDY; DNA END JOINING REPAIR; DRUG TREATMENT FAILURE; GENE OVEREXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IONIZING RADIATION; KERATINOCYTE; MALE; MALIGNANT TRANSFORMATION; MASS SPECTROMETRY; MOUSE; MOUSE MODEL; NONHUMAN; ONCOGENE; SENSITIZATION; THYROID HORMONE RECEPTOR INTERACTOR 13 GENE; TUMOR XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; CARCINOMA, SQUAMOUS CELL; CELL MOTION; CELL TRANSFORMATION; CHICK EMBRYO; CHORIOALLANTOIS; DOUBLE STRANDED DNA BREAK; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK NEOPLASMS; METABOLISM; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSFORMED CELL LINE; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DNA BREAKS, DOUBLE-STRANDED; DNA END-JOINING REPAIR; DNA-ACTIVATED PROTEIN KINASE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS, SUBCUTANEOUS; KERATINOCYTES; MICE; MICE, NUDE; NIH 3T3 CELLS; NUCLEAR PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84905460114     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10726     Document Type: Erratum

References (63)

1. Leemans, C. R., Braakhuis, B. J. & Brakenhoff, R. H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 11, 9-22 (2011
2. Jemal, A., Siegel, R., Xu, J. &Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. 60, 277-300 (2010
3. Chapman, J. R., Taylor, M. R. & Boulton, S. J. Playing the end game: DNA double-strand break repair pathway choice. Mol. Cell 47, 497-510 (2012
4. Kass, E. M. & Jasin, M. Collaboration and competition between DNA doublestrand break repair pathways. FEBS Lett. 584, 3703-3708 (2010
5. Jeggo, P. A. & Lobrich, M. DNA double-strand breaks: their cellular and clinical impact? Oncogene 26, 7717-7719 (2007 (Pubitemid 350242451)
6. Collis, S. J., DeWeese, T. L., Jeggo, P. A. & Parker, A. R. The life and death of DNA-PK. Oncogene 24, 949-961 (2005 (Pubitemid 40313872)
7. Bhalla, N. & Dernburg, A. F. A conserved checkpoint monitors meiotic chromosome synapsis in Caenorhabditis elegans. Science 310, 1683-1686 (2005 (Pubitemid 41780791)
8. Wu, H. Y. & Burgess, S. M. Two distinct surveillance mechanisms monitor meiotic chromosome metabolism in budding yeast. Curr. Biol. 16, 2473-2479 (2006 (Pubitemid 44894924)
9. Li, X. C., Bolcun-Filas, E. & Schimenti, J. C. Genetic evidence that synaptonemal complex axial elements govern recombination pathway choice in mice. Genetics 189, 71-82 (2011
10. Li, X. C. & Schimenti, J. C. Mouse pachytene checkpoint 2 (trip13) is required for completing meiotic recombination but not synapsis. PLoS Genet. 3, e130 (2007
11. Agrawal, N. et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333, 1154-1157 (2011
12. Cromer, A. et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 23, 2484-2498 (2004 (Pubitemid 38520746)
13. Estilo, C. L. et al. Oral tongue cancer gene expression profiling: identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 9, 11 (2009
14. Ye, H. et al. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 9, 69 (2008
15. Kuriakose, M. A. et al. Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol. Life Sci. 61, 1372-1383 (2004 (Pubitemid 38822426)
16. Ginos, M. A. et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res. 64, 55-63 (2004 (Pubitemid 38114082)
17. Toruner, G. A. et al. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet. Cytogenet. 154, 27-35 (2004 (Pubitemid 39286169)
18. Eymin, B., Leduc, C., Coll, J. L., Brambilla, E. & Gazzeri, S. p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene 22, 1822-1835 (2003 (Pubitemid 36513141)
19. Shih, C., Padhy, L. C., Murray, M. & Weinberg, R. A. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290, 261-264 (1981 (Pubitemid 11149660)
20. Li, A. Y. et al. Suppression of nonhomologous end joining repair by overexpression of HMGA2. Cancer Res. 69, 5699-5706 (2009
21. Fernandez-Capetillo, O., Allis, C. D. & Nussenzweig, A. Phosphorylation of histone H2B at DNA double-strand breaks. J. Exp. Med. 199, 1671-1677 (2004 (Pubitemid 38822000)
22. Neuwald, A. F., Aravind, L., Spouge, J. L. & Koonin, E. V. AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res. 9, 27-43 (1999 (Pubitemid 29095146)
23. Adamo, A. et al. Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. Mol. Cell 39, 25-35 (2010
24. Muntean, A. G. et al. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. Cancer Cell 17, 609-621 (2010
25. Nesvizhskii, A. I., Keller, A., Kolker, E. & Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658
26. Seluanov, A., Mao, Z. & Gorbunova, V. Analysis of DNA double-strand break (DSB) repair in mammalian cells. J. Vis. Exp. 8, 43 (2010
27. Ding, J., Miao, Z. H., Meng, L. H. & Geng, M. Y. Emerging cancer therapeutic opportunities target DNA-repair systems. Trends Pharmacol. Sci. 27, 338-344 (2006 (Pubitemid 43870126)
28. Liu, M. et al. The histone methyltransferase EZH2 mediates tumor progression on the chick chorioallantoic membrane assay, a novel model of head and neck squamous cell carcinoma. Transl. Oncol. 6, 273-281 (2013
29. Tome, S. et al. MSH2 ATPase domain mutation affects CTG-CAG repeat instability in transgenic mice. PLoS Genet. 5, e1000482 (2009
30. Karata, K., Inagawa, T., Wilkinson, A. J., Tatsuta, T. & Ogura, T. Dissecting the role of a conserved motif (the second region of homology) in the AAA family of ATPases. Site-directed mutagenesis of the ATP-dependent protease FtsH. J. Biol. Chem. 274, 26225-26232 (1999
31. Urba, S. et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J. Clin. Oncol. 24, 593-598 (2006 (Pubitemid 46630421)
32. Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N. & Szallasi, Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38, 1043-1048 (2006 (Pubitemid 44325930)
33. Kang, J. U., Koo, S. H., Kwon, K. C., Park, J. W. & Kim, J. M. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet. Cytogenet. 182, 1-11 (2008 (Pubitemid 351323956)
34. Rhodes, D. R. et al. Large-scale meta-Analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl Acad. Sci. USA 101, 9309-9314 (2004 (Pubitemid 38812872)
35. Tipton, A. R. et al. Identification of novel mitosis regulators through data mining with human centromere/kinetochore proteins as group queries. BMC Cell Biol. 13, 15 (2012
36. Larkin, S. E. et al. Identification of markers of prostate cancer progression using candidate gene expression. Br. J. Cancer 106, 157-165 (2012
37. van Kester, M. S. et al. A meta-Analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides. J. Invest. Dermatol. 132, 2050-2059 (2012
38. Wojtasz, L. et al. Mouse HORMAD1 and HORMAD2, two conserved meiotic chromosomal proteins, are depleted from synapsed chromosome axes with the help of TRIP13 AAA-ATPase. PLoS Genet. 5, e1000702 (2009
39. Zanders, S., Sonntag Brown, M., Chen, C. & Alani, E. Pch2 modulates chromatid partner choice during meiotic double-strand break repair in Saccharomyces cerevisiae. Genetics 188, 511-521 (2011
40. Cahill, D., Connor, B. & Carney, J. P. Mechanisms of eukaryotic DNA double strand break repair. Front. Biosci. 11, 1958-1976 (2006 (Pubitemid 43253408)
41. Joyce, E. F. & McKim, K. S. Drosophila PCH2 is required for a pachytene checkpoint that monitors double-strand-break-independent events leading to meiotic crossover formation. Genetics 181, 39-51 (2009
42. San-Segundo, P. A. & Roeder, G. S. Pch2 links chromatin silencing to meiotic checkpoint control. Cell 97, 313-324 (1999 (Pubitemid 29214588)
43. Shahi, A. et al. Mismatch-repair protein MSH6 is associated with Ku70 and regulates DNA double-strand break repair. Nucleic Acids Res. 39, 2130-2143 (2011
44. Holloman, W. K. Unraveling the mechanism of BRCA2 in homologous recombination. Nat. Struct. Mol. Biol. 18, 748-754 (2011
45. Ohnishi, T., Mori, E. & Takahashi, A. gH2AX (Springer, 2008
46. Britten, R. A. Modification of Radiosensitivity Following Chemotherapy Exposure: Potential Implications for Combined-Modality Therapy (Kluwer Academic Publishers, 2002
47. Adachi, N., Ishino, T., Ishii, Y., Takeda, S. & Koyama, H. DNA ligase IV-deficient cells are more resistant to ionizing radiation in the absence of Ku70: implications for DNA double-strand break repair. Proc. Natl Acad. Sci. USA 98, 12109-12113 (2001 (Pubitemid 32959835)
48. Moeller, B. J. et al. DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy. Clin. Cancer Res. 17, 2035-2043 (2011
49. Deriano, L. & Roth, D. B. Modernizing the nonhomologous end-joining repertoire: alternative and classical NHEJ share the stage. Annu. Rev. Genet. 47, 433-455 (2013
50. Guirouilh-Barbat, J., Rass, E., Plo, I., Bertrand, P. & Lopez, B. S. Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends. Proc. Natl Acad. Sci. USA 104, 20902-20907 (2007
51. Haber, J. E. Alternative endings. Proc. Natl Acad. Sci. USA 105, 405-406 (2008 (Pubitemid 351171719)
52. Banerjee, R. et al. The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma. Oncogene 30, 4339-4349 (2011
53. Brenner, J. C. et al. Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck 32, 417-426 (2010
54. Lingen, M. W., Polverini, P. J. & Bouck, N. P. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-Angiogenic. Am. J. Pathol. 149, 247-258 (1996 (Pubitemid 26230996)
55. Fischbach, C. et al. Engineering tumors with 3D scaffolds. Nat. Methods 4, 855-860 (2007 (Pubitemid 350055585)
56. Amornphimoltham, P. et al. Rab25 regulates invasion and metastasis in head and neck cancer. Clin. Cancer Res. 19, 1375-1388 (2013
57. Mitra, R. S. et al. Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma. Cancer Res. 68, 3959-3969 (2008
58. Zhang, Z. et al. Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma. Am. J. Pathol. 168, 585-596 (2006 (Pubitemid 43271156)
59. Mitra, R. S. et al. Rap1A and rap1B ras-family proteins are prominently expressed in the nucleus of squamous carcinomas: nuclear translocation of GTP-bound active form. Oncogene 22, 6243-6256 (2003 (Pubitemid 37281654)
60. Banerjee, R., Henson, B. S., Russo, N., Tsodikov, A. & D'Silva, N. J. Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma. Cell Signal 23, 1110-1118 (2011
61. Franken, N. A., Rodermond, H. M., Stap, J., Haveman, J. & van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc. 1, 2315-2319 (2006
62. Smeaton, M. B., Miller, P. S., Ketner, G. & Hanakahi, L. A. Small-scale extracts for the study of nucleotide excision repair and non-homologous end joining. Nucleic Acids Res. 35, e152 (2007
63. Lanzetta, P. A., Alvarez, L. J., Reinach, P. S. & Candia, O. A. An improved assay for nanomole amounts of inorganic phosphate. Anal. Biochem. 100, 95-97 (1979). (Pubitemid 10157636)